BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 71202)

  • 1. Humoral components in tumor-bearing animals that inhibit the appearance of immunogenicity on tumor cells.
    Tanino T; Saito M; Egawa K
    Cancer Res; 1977 Nov; 37(11):4009-15. PubMed ID: 71202
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.
    Tagliabue A; Herberman RB; Arthur LO; McCoy JL
    Cancer Res; 1979 Jan; 39(1):35-41. PubMed ID: 83909
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of target proteins participating in a lectin-dependent macrophage-mediated cytotoxic reaction.
    Ohkuma Y; Komano H; Natori S
    Cancer Res; 1985 Jan; 45(1):288-92. PubMed ID: 3965139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
    Pitzurra M; Marconi P; Bistoni F
    Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
    Hakin AA
    Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron microscope study of antigens in cells of mouse mammary tumor cell lines by peroxidase-labeled antibodies in sera of mammary tumor-bearing mice and of patients with breast cancer.
    Hoshino M; Dmochowski L
    Cancer Res; 1973 Nov; 33(11):2551-61. PubMed ID: 4355972
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 12. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of shared nonviral tumor-associated transplantation-type antigens among C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1984 May; 44(5):1876-9. PubMed ID: 6201265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell line-specific cell surface components of hypotetraploid ascites mammary carcinoma cells inducing humoral reactions in the syngeneic host.
    Tanino T; Saito M; Egawa K
    Int J Cancer; 1976 Jun; 17(6):736-41. PubMed ID: 59709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A; Manson LA
    Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic methods for the identification of cell types. II. Expression of normal mouse mammary epithelial cell antigens in mammary neoplasia.
    Ceriani RL; Peterson JA; Abraham S
    J Natl Cancer Inst; 1978 Sep; 61(3):747-51. PubMed ID: 80454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.